Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Calliditas Confident Of Setanaxib's Potential Despite Unclear Data

07 May 2024

• By Kevin Grogan

Renee Aguiar-Lucander — Renée Aguiar-Lucander • Source: Calliditas

Related Content

Calliditas Spies Chinese Market As Tarpeyo Continues Upwards Sales Curve

15 Nov 2022

Stada Poised To Launch As Calliditas Finally Wins EU Nod For Kinpeygo

20 May 2022

Related Companies

Calliditas Therapeutics AB

Merck & Co., Inc.

Everest Medicines Limited

Additional Topics

Clinical Trials Strategy Research & Development Cancer BioPharmaceutical

More from Anticancer

More from Therapy Areas

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.